ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TBIO Telesis Bio Inc

0.3135
-0.0407 (-11.49%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Telesis Bio Inc TBIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0407 -11.49% 0.3135 23:00:02
Open Price Low Price High Price Close Price Previous Close
0.3396 0.3162 0.3591 0.33 0.3542
more quote information »

Recent News

Date Time Source Heading
4/18/202408:00GLOBETelesis Bio Inc. announces strategic focus on game-changing..
3/28/202415:05GLOBETelesis Bio Reports Fourth Quarter and Full Year 2023..
3/05/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202417:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202419:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:00EDGAR2Form 8-K - Current report
2/26/202408:15GLOBETelesis Bio Announces Select Preliminary Fourth Quarter..
11/30/202316:00EDGAR2Form 8-K - Current report
11/13/202315:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:32EDGAR2Form 8-K - Current report
11/13/202315:22GLOBETelesis Bio Reports Third Quarter 2023 Financial Results
11/09/202316:00EDGAR2Form 8-K - Current report
11/07/202308:00GLOBETelesis Bio to Report Third Quarter Financial Results on..
11/03/202311:00GLOBETelesis Bio Announces Commercial Release of Cell-free..
10/24/202315:30EDGAR2Form 8-K - Current report
9/28/202314:48GLOBETelesis Bio Announces Commercial Release of BioXp® NGS..
9/22/202316:00EDGAR2Form 8-K - Current report
8/29/202315:05GLOBETelesis Bio Appoints William J. Kullback Chief Financial..
8/29/202315:02EDGAR2Form 8-K - Current report
8/11/202305:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:17EDGAR2Form 8-K - Current report
8/10/202315:05GLOBETelesis Bio Reports Second Quarter 2023 Financial Results
8/03/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/03/202316:00GLOBETelesis Bio to Report Second Quarter Financial Results on..
7/27/202316:28EDGAR2Form S-3 - Registration statement under Securities Act of..
7/07/202315:01EDGAR2Form 8-K - Current report
6/08/202308:05GLOBETelesis Bio to Present at Jefferies Healthcare Conference..
6/06/202302:00GLOBETelesis Bio to Present at Antibody Engineering and..
6/05/202316:30GLOBETelesis Bio Announces Closing of $28.0 Million Private..
5/31/202316:29GLOBETelesis Bio Secures Financing of $28.0 Million
5/23/202308:00GLOBETelesis Bio to Present at SynBioBeta 2023
5/22/202311:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
5/18/202309:00GLOBETelesis Bio Announces First Commercial Shipment of BioXp®..
5/15/202308:00GLOBETelesis Bio to Present at Protein Engineering Summit (PEGS..
5/11/202315:05GLOBETelesis Bio Reports First Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock